Management of Elevated INR

Assessment and Initial Management

• The American College of Cardiology recommends that for a patient with an INR of 6, the next 1-2 doses of warfarin should be omitted and vitamin K1 1-2.5 mg should be administered orally, especially if the patient has risk factors for bleeding 1, 2
• For a patient with INR 6, first assess for the presence of bleeding and risk factors for bleeding, according to the American College of Cardiology 1

Management Algorithm for INR 6 Without Bleeding

• The American College of Cardiology suggests omitting the next 1-2 doses of warfarin for a patient with an INR of 6 without bleeding 1, 2
• The American College of Cardiology recommends administering vitamin K1 1-2.5 mg orally, especially if the patient has risk factors for bleeding 1, 2
• Monitor INR within 24 hours to ensure it's decreasing appropriately, as recommended by the American College of Cardiology 1, 3

Evidence Supporting Oral Vitamin K

• Oral vitamin K1 1-2.5 mg is sufficient when the INR is between 4 and 10, according to the American College of Cardiology 1, 2
• A prospective study showed that oral vitamin K1 1 mg reduced the INR in 95% of patients within 24 hours 2
• Oral administration is preferred over intravenous due to the risk of anaphylactoid reactions with IV administration, as stated in the Chest journal 4, 5

Special Considerations

• If the patient requires urgent surgery or dental extraction, vitamin K1 2-5 mg can be given orally to reduce INR within 24 hours, according to the American College of Cardiology 1, 3
• For patients with mechanical heart valves, caution is needed with vitamin K administration to avoid valve thrombosis if INR falls too rapidly, as recommended by the European Heart Journal 6, 7

Management of Bleeding Complications

• If the patient with INR 6 presents with bleeding, management differs significantly, according to the Chest journal 4, 5
• For minor bleeding, oral vitamin K 1-2.5 mg and close monitoring are recommended by the American College of Cardiology 1, 2, 3
• For major bleeding, hospital admission, vitamin K 5-10 mg by slow IV infusion, plus prothrombin complex concentrate (PCC) or fresh frozen plasma (FFP) are recommended by the Chest journal and Critical Care 4, 8

Follow-up and Prevention

• Investigate the cause of elevated INR, such as drug interactions, dietary changes, or illness, as recommended by the Journal of the American Geriatrics Society (JAGS) 9
• More frequent INR monitoring may be required in older adults who have an increased risk of hemorrhage, according to the Journal of the American Geriatrics Society (JAGS) 9

Common Pitfalls to Avoid

• Administering vitamin K intravenously when not necessary can lead to anaphylactic reactions, as stated in the Chest journal 4, 5
• Using subcutaneous vitamin K can result in an unpredictable and sometimes delayed response, according to the American College of Cardiology 2
• Giving excessive doses of vitamin K can lead to warfarin resistance, as recommended by the American College of Cardiology 2
• Failing to identify and address the underlying cause of the elevated INR can lead to further complications, according to the Journal of the American Geriatrics Society (JAGS) 9

Vitamin K Dosing for Elevated INR

Management of Supratherapeutic INR

• The American College of Cardiology suggests that for patients with mechanical heart valves and supratherapeutic INR (>5.0), the benefit of individualized treatment with oral vitamin K is uncertain 10
• The American College of Cardiology recommends considering 4-factor prothrombin complex concentrate (PCC) as first-line therapy for major bleeding in patients with elevated INR 10

Warfarin Reversal in Adults

Route Selection and Technique

• Intravenous administration is the preferred route for rapid warfarin reversal because it achieves a predictable INR reduction within 4–6 hours, compared with 18–24 hours for oral dosing and unpredictable results with subcutaneous injection. 11
• Phytonadione (vitamin K) should be diluted in 25–50 mL of normal saline and infused slowly over 15–30 minutes, never exceeding 1 mg per minute, to minimize adverse reactions. This slow‑infusion technique also eliminates the anaphylactic reactions previously reported with rapid IV administration. 11
• Subcutaneous administration of vitamin K yields an unpredictable pharmacologic response and is therefore not recommended for urgent warfarin reversal. 11

Dosing Algorithm for Major Bleeding

• For adults with a markedly elevated INR and major bleeding, give vitamin K 5–10 mg intravenously by slow infusion and administer 4‑factor prothrombin complex concentrate (4F‑PCC) according to the INR‑based dosing table below. This combined approach provides immediate factor repletion while vitamin K restores hepatic synthesis of clotting factors. [12][13][14][15]

• Vitamin K alone does not produce an immediate correction of coagulopathy; its effect on INR typically requires 4–6 hours. Consequently, vitamin K must be combined with 4F‑PCC when rapid reversal is needed. 11

Critical Pitfalls to Avoid

• Do not rely on vitamin K monotherapy for major bleeding, as it cannot achieve the rapid hemostatic correction required; always pair it with 4F‑PCC. [12][11]
• Avoid the subcutaneous route for urgent reversal because of its unreliable absorption. 11
• Never administer IV vitamin K faster than 1 mg per minute; exceeding this rate increases the risk of anaphylactoid reactions. The recommended slow‑infusion protocol (15–30 minutes for 25–50 mL diluent) mitigates this risk. 11